Louis H. Morrone
CIK: 0001867666
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABBOTT LABORATORIES
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 12, 2026ABT
ABBOTT LABORATORIES
Discretionary(I)Indirect12 shares at avg. $107.99$1K - Aug 11, 2026ABT
ABBOTT LABORATORIES
Sale(S)Direct5.9K shares at avg. $109.83$643K - Jun 30, 2026ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct269 shares at avg. $92.71$25K - Mar 2, 2026ABT
ABBOTT LABORATORIES
Sale(S)Direct1.1K shares at avg. $115.58$132K - Feb 27, 2026ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct4K shares at avg. $116.26$470K - Feb 24, 2026ABT
ABBOTT LABORATORIES
Award(A)Direct15.4K shares- - Jun 30, 2025ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct269 shares at avg. $134.38$36K - Mar 3, 2025ABT
ABBOTT LABORATORIES
Sale(S)Direct1.1K shares at avg. $138.17$154K - Feb 28, 2025ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct4.4K shares at avg. $135.87$596K - Feb 25, 2025ABT
ABBOTT LABORATORIES
Award(A)Direct10.2K shares- - Jan 28, 2025ABT
ABBOTT LABORATORIES
Sale(S)Indirect2.6K shares at avg. $127.39$337K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | ABT ABBOTT LABORATORIES | Discretionary(I) | 12 | $107.99 | $1,296 | Indirect |
| Aug 11, 2026 | ABT ABBOTT LABORATORIES | Sale(S) | 5,850 | $109.83 | $642,506 | Direct |
| Jun 30, 2026 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 269 | $92.71 | $24,939 | Direct |
| Mar 2, 2026 | ABT ABBOTT LABORATORIES | Sale(S) | 1,144 | $115.58 | $132,224 | Direct |
| Feb 27, 2026 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 4,040 | $116.26 | $469,690 | Direct |
| Feb 24, 2026 | ABT ABBOTT LABORATORIES | Award(A) | 15,418 | - | $0 | Direct |
| Jun 30, 2025 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 269 | $134.38 | $36,148 | Direct |
| Mar 3, 2025 | ABT ABBOTT LABORATORIES | Sale(S) | 1,111 | $138.17 | $153,507 | Direct |
| Feb 28, 2025 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 4,386 | $135.87 | $595,926 | Direct |
| Feb 25, 2025 | ABT ABBOTT LABORATORIES | Award(A) | 10,232 | - | - | Direct |
| Jan 28, 2025 | ABT ABBOTT LABORATORIES | Sale(S) | 2,644 | $127.39 | $336,819 | Indirect |
1-11 of 11 transactions
About Morrone Louis H.
Morrone Louis H. (SEC CIK 0001867666) files insider reports with the SEC as EXECUTIVE VICE PRESIDENT of ABBOTT LABORATORIES (ABT).
Signal8 holds 8 ownership filings by Morrone Louis H., all Form 4s, filed between Jan 30, 2025 and Aug 13, 2026. Those filings report 11 transactions, from Jan 28, 2025 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Morrone Louis H.'s filings is in ABBOTT PARK, IL.
Recent filings by Morrone Louis H.
- Aug 12, 2026: Discretionary transaction transaction of ABT shares (Form 4, code I).
- Aug 11, 2026: Open-market sale of ABT shares (Form 4, code S).
- Jun 30, 2026: Tax withholding of ABT shares (Form 4, code F).
- Mar 2, 2026: Open-market sale of ABT shares (Form 4, code S).
- Feb 27, 2026: Tax withholding of ABT shares (Form 4, code F).
Other insiders filing for ABBOTT LABORATORIES (ABT)
- Stratton John G, Director
- Gonzalez Patricia Paola, Director
- Conroy Kevin T, Director
- Ahuja Nita, Director
- Roman Michael F, Director
- MCCOY JOHN A. JR., VICE PRESIDENT AND CONTROLLER